Abstract:There is large interest in the early diagnosis of Alzheimer's disease (AD) using machine learning. The NIH-sponsored Alzheimer's Disease Connectome Project (ADCP), a multi-center MRI, PET, and behavioral study of brain connectivity in AD, has a specific aim of accurately staging AD throughout its progression on an individual basis. It uses state-of-the-art MRI imaging techniques which allow for building reliable machine learning models. In this ongoing project, we are training models with the MRI structural brain features to separate between healthy controls and a group of AD and mild cognitive impairment (MCI) patients. Data from 12 patients (age=70.8±6.6 years, 7 males, 4 AD patients), and 20 healthy controls (age=68.9±6.2 years, 11 males), enrolled in ADCP, were analyzed. The two groups matched in age (p=0.45) and gender ratio (p=0.85). All images were acquired with 3T GE 750 scanners. T1-weighted images were acquired using a magnetization prepared gradient echo sequence (TR/TE=604ms/2.516ms, 0.8mm isotropic). Data were pre-processed using FreeSurfer-based Human Connectome Project (HCP) processing pipelines. 269 structural features were extracted, which include cortical thicknesses, surface areas, and subcortical and global volumes. They were normalized with the individual intracranial volume and then with the standardized z-score transform. 3 traditional binary classification machine learning models were trained in Matlab: support vector machine (SVM), linear discriminant analysis (LDA), and naïve Bayes (NB) classifiers. We applied a t-test based filter selection method, where only a group of features with the largest group mean differences in the training set enters the training. For performance estimation, we used leave-one-out cross validation (LOOCV) and the area-under-the-curve (AUC). SVM model classified the two groups with 90.6% accuracy (sensitivity=83.3%, specificity=95.0%, AUC=0.78, 23 features). NB model reached 84.38% (sensitivity=83.3%, specificity=85.0%, AUC=0.83, 10 features). Bilateral temporal pole volumes and right entorhinal volume were the most discriminating features. Linear traditional machine learning models were able to separate between AD/MCI patients and healthy controls with mid-80 to 90% accuracy. This is promising as it is known that non-linear, deep learning methods will outperform these traditional models given more data in the future. Building an automated model to classify Alzheimer's patients is expected to aid early diagnosis . A t-test based filter selection method was used to let only a certain number of features with the most group difference to be used in the training. SVM reached the highest LOOCV accuracy at 90.6% using 23 features. Bilateral temporal pole volumes showed the most group differences and helped machine learning separate the two groups. The volumes are noticeably reduced in MCI and AD patients compared to the healthy controls.

Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Weakly Supervised Learning Analysis of Aβ Plaque Distribution in the Whole Rat Brain

Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-β Deposits and Activated Microglia

Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum

Combined segmentation and classification of Alzheimer’s disease pathology distribution within human hippocampal subregions

Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer's disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI

Transcriptome-guided Amyloid Imaging Genetic Analysis Via a Novel Structured Sparse Learning Algorithm.

Deep Learning Patterns of Aβ Accumulation in Alzheimer’s Disease

Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases

Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders

A quantitative analysis of Alzheimers Disease and construction of an early Alzheimers detection deep learning system (EADDLS) using MRI data via machine learning along with ADmod: spatiotemporal-aware brain-amyloidβ growth model, using deep encoder-decoder networks about MRI

Automated deep learning segmentation of neuritic plaques and neurofibrillary tangles in Alzheimer disease brain sections using a proprietary software

Clinical Study of PET‐validated EEG‐machine learning algorithm predicting brain amyloid pathology in pre‐dementia Alzheimer’s disease

CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING

Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice

Enhancing Amyloid PET Quantification: MRI-Guided Super-Resolution Using Latent Diffusion Models

Elucidating the neuropathological and molecular heterogeneity of amyloid-beta and tau in Alzheimer's disease through machine learning and transcriptomic integration

Three-dimensional Quantitative Analysis of Amyloid Plaques in the Whole Brain with High Voxel Resolution

Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer's Disease and Mild Cognitive Impairment.